NUGS - Cannabis Strategic Ventures

Other OTC - Other OTC Delayed Price. Currency in USD
Show:
Income Statement
Balance Sheet
Cash Flow
Annual

Income Statement

All numbers in thousands
Breakdown
ttm
3/30/2019
3/30/2018
3/30/2017
3/30/2016
Total Revenue
841
702
345
0
0
Cost of Revenue
865
681
96
0
0
Gross Profit
-24
21
249
0
0
Operating Expenses
Research Development
-
-
-
-
-
Selling General and Administrative
22,260
21,137
4,699
18
97
Total Operating Expenses
22,260
21,137
4,699
18
97
Operating Income or Loss
-22,284
-21,116
-4,450
-18
-97
Interest Expense
-
-
1
0
0
Total Other Income/Expenses Net
-509
-320
3,821
104
23
Income Before Tax
-22,786
-21,433
-617
86
-74
Income Tax Expense
0
0
2
0
0
Income from Continuing Operations
-22,786
-21,433
-619
86
-74
Net Income
-22,774
-21,433
-619
86
-74
Net Income available to common shareholders
-22,774
-21,433
-619
86
-74
Reported EPS
Basic
-
-0.08
-0.00
0.00
-0.00
Diluted
-
-0.08
-0.00
0.00
-0.00
Weighted average shares outstanding
Basic
-
268,377
193,279
21,974
18,770
Diluted
-
268,377
193,279
21,974
18,770
EBITDA
-
-21,116
-616
-18
-73